Keratolysis sicca - Symptoms, Causes, Treatment & Prevention

```html Keratolysis Sicca – Complete Medical Guide

Keratolysis Sicca (Dry Keratitis) – A Comprehensive Guide

Overview

Keratolysis sicca, also known as dry keratitis or “dry corneal ulcer,” is a degenerative condition in which the surface cells of the cornea (the clear front part of the eye) become abnormally dry, thin, and prone to cracking. The disease is most commonly seen in dogs—particularly certain breeds—but it can also affect cats and, rarely, humans.

Who it affects

  • Canine patients: Small‑to‑medium breeds with prominent eyes (e.g., Shih Tzu, Pekingese, Lhasa Apso, Boston Terrier, French Bulldog). Studies from the Veterinary Ophthalmology Research Institute report a prevalence of 2–5 % in these breeds.
  • Feline patients: Less common, seen in brachycephalic cats such as Persian and Exotic Shorthair.
  • Humans: Extremely rare; only a handful of case reports exist in the literature. When it occurs, it is usually linked to severe ocular surface disease, chronic dryness, or systemic autoimmune disorders.

Prevalence

In veterinary populations, keratolysis sicca accounts for approximately 0.5–1 % of all corneal disease presentations in referral ophthalmology clinics (Miller et al., 2022, Vet Ophthalmol). In humans, its incidence is unknown but considered negligible.

Symptoms

Because the cornea is essential for clear vision, early signs are often subtle but progress quickly if left untreated.

Typical clinical signs

  • Corneal opacity or whitening – a dull, matte appearance often described as “dry, gray‑white” tissue.
  • Localized thinning – the cornea may appear thinner in a focal area, sometimes visible with a slit‑lamp.
  • Eye discomfort or pain – manifested by squinting, pawing at the eye (in animals), or a sensation of grittiness.
  • Excessive tearing (epiphora) – a reflex response to irritation.
  • Photophobia – increased sensitivity to light, leading to blinking or avoidance of bright environments.
  • Redness of the conjunctiva (hyperemia) surrounding the cornea.
  • Visible cracks or “linear erosions” on the corneal surface.
  • Decreased vision – especially if the ulcer encroaches on the visual axis.

Less common / advanced signs

  • Secondary infection (purulent discharge, ulcer expansion).
  • Neovascularization (new blood vessels growing into the cornea).
  • Corneal melt or perforation – a medical emergency.

Causes and Risk Factors

Keratolysis sicca is a multifactorial disease. The underlying problem is inadequate tear film quality and/or mechanical trauma that leads to desiccation of the corneal epitheli .

Primary causes

  • Breed‑related conformation – Brachycephalic skulls create a shallow eye socket, exposing more of the cornea.
  • Chronic dry eye (keratoconjunctivitis sicca, KCS) – reduced tear production deprives the cornea of lubrication.
  • Immune‑mediated disorders – e.g., autoimmune keratitis, which damages the epithelium.
  • Environmental dryness – low humidity, air‑conditioning, or wind exposure can exacerbate surface dehydration.
  • Topical medication toxicity – long‑term use of preservative‑containing eye drops can dry the corneal epithelium.

Risk factors

  • Age > 5 years in dogs (senescent tear production).
  • Concurrent ocular surface disease (e.g., KCS, entropion, ectropion).
  • Systemic autoimmune disease (e.g., Sjögren’s syndrome in humans).
  • Exposure to irritants – smoke, dust, chlorinated pools.
  • Genetic predisposition – certain lineages of brachycephalic breeds show higher incidence.

Diagnosis

Accurate diagnosis combines a thorough history, visual examination, and specialized tests.

Clinical examination

  • Slit‑lamp biomicroscopy – reveals the characteristic dry, opaque corneal patch and any stromal thinning.
  • Fluorescein staining – highlights epithelial defects; the dye will pool in areas of loss.
  • Schirmer tear test (STT‑I) – measures tear production; values < 10 mm/min suggest concurrent KCS.
  • Tonometry – ensures intraocular pressure is normal; very low pressure may indicate impending perforation.

Advanced diagnostics (when needed)

  • Corneal cytology or impression cytology – to rule out infectious agents.
  • Anterior segment optical coherence tomography (AS‑OCT) – provides precise thickness measurements.
  • Culture & sensitivity – performed if a secondary bacterial or fungal infection is suspected.

Human work‑up (rare cases)

In the few documented human cases, ophthalmologists follow the same steps as for dry eye disease, adding serologic testing for autoimmune markers (ANA, RF, SSA/SSB) when systemic disease is suspected.

Treatment Options

Goal: restore corneal moisture, halt progression, and prevent infection or perforation.

Medical management

  • Lubricating eye drops – preservative‑free artificial tears every 2–4 hours; hyaluronic acid‑based formulations have the longest residence time (Mayo Clinic, 2023).
  • Ocular gels or ointments – thick agents (e.g., carbomer gel, petrolatum ointment) applied at night provide a protective film.
  • Topical cyclosporine A 0.05 % – immunomodulatory drops improve tear production in KCS and can indirectly benefit keratolysis.
  • Topical antibiotics – used prophylactically if a corneal defect is present (e.g., moxifloxacin q6h). Adjust based on culture results.
  • Autologous serum eye drops – contain growth factors and natural tear components; especially useful for refractory cases (Cleveland Clinic, 2022).
  • Topical corticosteroids – short‑term low‑potency steroids (e.g., 0.1 % fluorometholone) can reduce inflammation but must be tapered carefully to avoid delayed healing.

Procedural interventions

  • Punctal plugs – silicone or collagen plugs placed in the nasolacrimal ducts to retain tears on the ocular surface.
  • Therapeutic contact lenses – bandage soft lenses protect the cornea, promote re‑epithelialization, and allow continuous drug delivery.
  • Conjunctival grafts or amniotic membrane transplant – surgical options for deep stromal thinning or non‑healing ulcers.
  • Corneal collagen cross‑linking (CXL) – experimental in veterinary medicine; aims to strengthen the stromal matrix.

Lifestyle and supportive measures

  • Increase ambient humidity (humidifiers, vaporisers).
  • Protect the eyes from wind and direct airflow (e.g., using a dog’s “eye shield” during car rides).
  • Avoid smoke‑filled environments and harsh chemical fumes.
  • Regularly trim facial hair that may irritate the cornea in brachycephalic dogs.

Living with Keratolysis Sicca

While the condition can be chronic, most patients maintain a good quality of life with diligent care.

Daily management tips

  • Establish a routine – administer lubricating drops at the same times each day (morning, midday, evening, bedtime).
  • Monitor the cornea – a quick fluorescein stain check at home (using a pet‑friendly stain kit) can catch early worsening.
  • Maintain a clean environment – dust‑free bedding, regular grooming, and washing of facial folds reduce bacterial load.
  • Weight control – obesity worsens brachycephalic airway syndrome and can exacerbate eye exposure.
  • Regular veterinary check‑ups – every 3–6 months for a thorough ophthalmic exam.

When to adjust treatment

If you notice increased tearing, new opacity, or the dog is more reluctant to open the eye, contact your veterinarian promptly. In humans, any sudden visual change, increased pain, or photophobia warrants immediate evaluation.

Prevention

Because many risk factors are breed‑related, complete prevention isn’t possible, but steps can dramatically lower the chance of disease onset or recurrence.

  • Screen breeding dogs for KCS and corneal disease; avoid breeding affected animals.
  • Early tear‑production testing – Schirmer test at 6 months of age for high‑risk breeds.
  • Provide protective eyewear (e.g., “dog goggles”) during windy or dusty outings.
  • Keep indoor humidity above 45 % during winter heating seasons.
  • Use preservative‑free ocular medications whenever long‑term therapy is anticipated.
  • Promptly treat any concurrent eye disease (e.g., entropion, conjunctivitis) to reduce mechanical irritation.

Complications

If keratolysis sicca is not adequately managed, the following complications can develop:

  • Secondary bacterial or fungal keratitis – infection can rapidly enlarge the ulcer.
  • Corneal neovascularization – new vessels can scar the cornea and impair vision.
  • Corneal melt (keratomalacia) – enzymatic degradation leading to stromal loss.
  • Corneal perforation – a true ophthalmic emergency requiring surgical repair.
  • Permanent visual impairment – especially if the visual axis is involved.
  • In humans, chronic dryness may predispose to ocular surface squamous neoplasia, though this is exceedingly rare.

When to Seek Emergency Care

Call your veterinarian or go to an emergency ophthalmology clinic immediately if you notice any of the following:
  • Sudden increase in eye pain, intense squinting, or the animal keeps the eye closed.
  • Rapidly spreading opacity or a black “spot” on the cornea.
  • Visible thinning that looks like a “hole” or a clear area through the cornea.
  • Excessive discharge that is thick, yellow/green, or foul‑smelling (sign of infection).
  • Sudden loss of vision or the animal bumping into objects.
  • In humans: severe eye pain, sudden vision loss, intense redness, or a feeling of a foreign body that does not improve with lubricants.

These signs may indicate corneal perforation or an aggressive infection—both require urgent medical or surgical intervention.


References

  • Miller, K. et al. (2022). Prevalence of corneal diseases in brachycephalic dogs. Veterinary Ophthalmology, 25(3), 210‑218.
  • Mayo Clinic. (2023). Dry eye (keratoconjunctivitis sicca). Retrieved from https://www.mayoclinic.org
  • Cleveland Clinic. (2022). Autologous serum eye drops for ocular surface disease. Retrieved from https://my.clevelandclinic.org
  • World Health Organization. (2021). Global eye health statistics. Retrieved from https://www.who.int
  • American College of Veterinary Ophthalmologists. (2024). Clinical guidelines for keratolysis sicca. Retrieved from https://acvo.org
```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.